Patent ID: 6884806
Filing Date: 2005-04-26
Classification: A61P,C07D

Abstract:
1. A compound of formula I: or a stereoisomer or pharmaceutically acceptable salt form thereof, wherein; A is selected from: —COR B is selected from: C and C—H, wherein the H is an α-H; the bridging portion of Ring C completes a 6 membered heterocyclic ring and consists of: 3 carbon atoms and 0 double bonds; the bridging portion of Ring C is substituted with 0-1 R the bridging portion of Ring D completes a 5-membered heterocyclic ring and consists of: 2-3 carbon atoms and 0-2 double bonds; the bridging portion of Ring D is substituted with 0-1 R R U is absent; X is absent; Y is absent; Z is selected from: a C U X Y Z provided that: R Q, at each occurrence, is independently selected from: H, a C R Q R R R R R R R R R alternatively, R R R R R alternatively, when two R alternatively, when two R R R R R p, at each occurrence, is selected from 0, 1, and 2; r, at each occurrence, is selected from 0, 1, 2, 3, and 4; and, r1, at each occurrence, is selected from 0, 1, 2, 3, and 4.